Suscribirse

IS MULTIPLE SCLEROSIS A RISK FACTOR FOR ATHEROSCLEROSIS? - 07/11/19

Doi : 10.1016/j.neurad.2019.10.002 
Burcu Yuksel, MD 1, , Pınar Koc, MD 2 , Eylem Ozaydin Goksu, MD 1 , Ertan Karacay, MD 1 , Fatma Kurtulus 1  : Ass. Prof., Yesim Cekin 3  : Ass. Prof., Yasemin Bicer Gomceli 1  : Ass. Prof.
1 Antalya Training and Research Hospital, Neurology Department, Muratpasa 07050 Antalya, TURKEY 
2 Antalya Training and Research Hospital, Radiology Department, Muratpasa 07050 Antalya, TURKEY 
3 Antalya Training and Research Hospital, Microbiology Department, Muratpasa 07050 Antalya, TURKEY 

Correspondance to: Antalya Research and Training Hospital, Neurology Department, 07050 Muratpaşa, Antalya, TURKEYAntalya Research and Training Hospital, Neurology DepartmentMuratpaşaAntalya07050TURKEY
En prensa. Manuscrito Aceptado. Disponible en línea desde el Thursday 07 November 2019
This article has been published in an issue click here to access

Highlights

CIMT seemed to be affected in patients with MS when comparing with healthy controls.who had similar demographic variables [age, sex, body mass index [BMI], blood pressure, and cholesterol levels].
During remission Hs-CRP has been found at normal levels.
Different disease-modifying therapies may have altered the inflammation process.

El texto completo de este artículo está disponible en PDF.

ABSTRACT

Background: Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system. We aimed to discuss possible predisposing factors to atherosclerosis such as carotid intima media thickness (CIMT) and high-sensitivity C-reactive protein (Hs-CRP) levels in MS.

Methods: Thirty-five ambulatory patients with relapsing-remitting MS (RRMS) (22 females and 13 males) and 34 healthy controls (21 females and 13 males) with similar demographic variables were included. Blood cell counts, cholesterol levels, vitamin D and B12, Hs-CRP levels, body mass index (BMI), history of smoking, and CIMT of both groups, Expanded Disability Status Scale (EDSS) scores, and disease duration of patients were recorded. Patients with a history of other vascular diseases such as hypertension, diabetes mellitus, peripheral artery disease, and acute relapses were excluded.

Results: Sixty-nine participants were included. The mean age of the study population was 35.8±7.1 years. Right CIMT was significantly greater in the patient population (p<0.001). Spearman’s correlation coefficient between age and right CIMT was r=0.41, p=0.01. When we compared the Hs-CRP with a cut-off value of ≤3, the right, left, and mean CIMT levels were not statistically significant (p=0.17; p=0.22; p=0.15). The mean serum vitamin D levels were higher in the patient group and this was statistically significant (p<0.001). The statistically significant factors identified with univariate analysis with p<0.2 were further entered into multivariate modelling.

Conclusion: CIMT seems to be affected in patients with MS by means of the disease itself and age. Thus, CIMT might reflect the predisposition to subclinical atherosclerosis more than Hs-CRP. Further investigation in a large MS population is still needed.

El texto completo de este artículo está disponible en PDF.

Keywords : atherosclerosis, multiple sclerosis, intima-media thickness, high-sensitivity C-reactive protein, inflammation



© 2019  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.